drugset / Trial / NCT01838863

Control of Major Bleeding After Trauma Study

NCT01838863

RandomizedParallel-groupOpen-labelTreatment

Summary

Bleeding is the most avoidable cause of death in trauma patients. Up to one-third of severely injured trauma patients are found to be coagulopathic and forty percent of the mortality following severe injury is due to uncontrollable hemorrhage in the setting of coagulopathy. It has been established that early administration of fresh frozen plasma decreases mortality following severe injury, replacing lost coagulation factors, improving the coagulopathy and restoring blood volume. This study will determine if giving plasma to severely injured trauma patients during ambulance transport versus after arrival to the hospital will help reduce hemorrhage, thus decreasing both total blood product administration and mortality.

Timeline

Start
2014-04-07
Primary completion
2017-04-03
Completion
2017-04-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Type AB plasma Unknown 2 unknown
Comparator sodium chloride Unknown Intravenous

Indications

No indication recorded.